Saundra Pelletier is the founder of Evofem Biosciences. Evofem Biosciences has raised $491M in total funding.
Saundra Pelletier serves as the Chief Executive Officer, President, and Executive Director of Evofem Biosciences since February 2015, and as interim Chair of the Board since November 2021. The company launched Phexxi®, a non-hormonal contraceptive, and acquired SOLOSEC®, an oral antibiotic. She led the company through its transition to the public market and four consecutive years of net sales growth.
Full founder directory · Investor directory · Company funding database · Fundraising library